공간 유전체학 및 전사체학 시장 규모, 점유율, 성장 분석 : 제공 서비스별, 샘플 유형별, 치료 영역별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Spatial Genomics & Transcriptomics Market size was valued at USD 427.4 Million in 2024 and is poised to grow from USD 472.7 Million in 2025 to USD 1058.35 Million by 2033, growing at a CAGR of 10.6% during the forecast period (2026-2033).

The global market for spatial genomics and transcriptomics is experiencing significant growth driven by the demand for precision medicine and the adoption of single-cell analysis technologies. Key factors such as increased investment in cancer and neuroscience research, advancements in sequencing and imaging platforms, and expanding drug discovery applications are propelling this market forward. The ability to map DNA and RNA in whole tissue samples enhances research in oncology, developmental biology, neuroscience, and immunology, fostering further market growth. Collaborative partnerships among sequencing platform providers, contract research organizations, and academia are creating new commercialization opportunities. However, challenges including high instrument costs, complex data analysis, limited platform standardization, and sample preparation difficulties may impede market penetration. Overall, the need for personalized medicine and genomic research fuels this dynamic landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Genomics & Transcriptomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Genomics & Transcriptomics Market Segments Analysis

Global spatial genomics & transcriptomics market is segmented by offering, sample type, therapeutic area, application, end user,and region. Based on offering, the market is segmented into instruments, consumables, software &analytics,and services. Based on sample type, the market is segmented into fresh frozen tissue, FFPE Tissue, fixed frozen tissue, cultured cells,and others. Based on therapeutic area, the market is segmented into oncology, neurology, immunology, infectious diseases, cardiovasculardiseases,and others.Based on application, the market is segmented into translational research, drug discovery & development, clinical diagnostics research, biomarker discovery, cell biology research,and others. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations (CROs), clinical & diagnostic laboratories,and others. Based onregion, the market is segmented into North America, Europe, Asia Pacific, Latin America,and Middle East & Africa.

Driver of the Global Spatial Genomics & Transcriptomics Market

One key market driver for the Global Spatial Genomics & Transcriptomics Market is the increasing demand for personalized medicine and precision therapeutics. As healthcare shifts towards tailored treatment options based on individual genetic and molecular profiles, spatial genomics and transcriptomics provide crucial insights into the spatial organization of cells and tissues. This technology allows researchers and clinicians to better understand disease mechanisms and heterogeneity, facilitating the development of targeted therapies. Moreover, advancements in imaging technologies and bioinformatics tools are enhancing the accessibility and applicability of these techniques, further fueling market growth as they become integral to modern biomedical research and clinical practices.

Restraints in the Global Spatial Genomics & Transcriptomics Market

One of the key market restraints for the global spatial genomics and transcriptomics market is the high cost associated with the advanced technologies and equipment required for spatial analysis. The complex protocols, need for specialized training, and the integration of sophisticated software can pose significant financial barriers for many research institutions and laboratories, particularly in developing regions. Additionally, concerns regarding data management, privacy, and standardization of methodologies further hinder widespread adoption. The financial burden often restricts access to cutting-edge techniques, limiting their use to well-funded organizations and thereby slowing the overall growth of the market.

Market Trends of the Global Spatial Genomics & Transcriptomics Market

The Global Spatial Genomics and Transcriptomics market is witnessing a significant trend driven by the integration of AI-powered analytical techniques. Machine learning algorithms and advanced computational methods are increasingly being employed to extract valuable insights from spatial genomics and transcriptomics datasets. This approach not only accelerates biomarker discovery but also facilitates a deeper understanding of cellular interactions within tissue structures. The emphasis on model explainability, cloud-based solutions, and streamlined data pipelines is enhancing competitiveness in spatial biology research. Consequently, this trend is paving the way for predictive modeling in preclinical studies, guiding drug-target identification, and optimizing data analysis and visualization processes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Spatial Genomics & Transcriptomics Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Software & Analytics
• Services

Global Spatial Genomics & Transcriptomics Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Fresh Frozen Tissue
• FFPE Tissue
• Fixed Frozen Tissue
• Cultured Cells
• Others

Global Spatial Genomics & Transcriptomics Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Neurology
• Immunology
• Infectious Diseases
• Cardiovascular Diseases
• Others

Global Spatial Genomics & Transcriptomics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Translational Research
• Drug Discovery & Development
• Clinical Diagnostics Research
• Biomarker Discovery
• Cell Biology Research
• Others

Global Spatial Genomics & Transcriptomics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Clinical & Diagnostic Laboratories
• Others

Global Spatial Genomics & Transcriptomics Market Size & CAGR (2026-2033)

• North America (Offering, Sample Type, Therapeutic Area, Application, End User)
  • US
  • Canada
• Europe (Offering, Sample Type, Therapeutic Area, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Sample Type, Therapeutic Area, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Sample Type, Therapeutic Area, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Sample Type, Therapeutic Area, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 10x Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Spatial Biology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vizgen, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Resolve Biosciences GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ionpath, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parse Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STOmics Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations